EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Best Pharmaceutical Stocks To Keep An Eye On - May 25th - Stock Observer
Wealthquest Corp Makes New Investment in AbbVie Inc. $ABBV
Two Paths to Growth: Johnson & Johnson vs AbbVie - AOL
AbbVie Inc. $ABBV Shares Purchased by Legal & General Group Plc
AbbVie Inc. $ABBV Shares Sold by Simplify Asset Management Inc.
Churchill Financial Advisors LLC Purchases Shares of 20,429 AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Holdings Raised by Genus Capital Management Inc.
Legal & General Group Plc Raises Stock Holdings in AbbVie Inc. $ABBV - Stock Observer
Wealthquest Corp Purchases New Position in AbbVie Inc. $ABBV - Daily Political
Choate Investment Advisors Sells 6,525 Shares of AbbVie Inc. $ABBV - Stock Observer
Prospera Financial Services Inc Sells 3,489 Shares of AbbVie Inc. $ABBV - Zolmax
Jefferies Financial Group Inc. Acquires 3,784 Shares of AbbVie Inc. $ABBV - Zolmax
First National Trust Co Reduces Stake in AbbVie Inc. $ABBV
Pathfinder Wealth Consulting Inc. Makes New Investment in AbbVie Inc. $ABBV - Stock Observer
Prospera Financial Services Inc Sells 3,489 Shares of AbbVie Inc. $ABBV - Daily Political
AbbVie's EMA Wins For Boey And MAVIRET Expand European Growth Story
Best Pharmaceutical Stocks To Keep An Eye On - May 23rd - Stock Observer
AbbVie (ABBV): 10 Best Low Risk Stocks to Buy in 2026
GPS Wealth Strategies Group LLC Trims Holdings in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Sold by GPS Wealth Strategies Group LLC
Guinness Asset Management LTD Sells 37,113 Shares of AbbVie Inc. $ABBV - Stock Observer
Mizuho Markets Americas LLC Boosts Holdings in AbbVie Inc. $ABBV - Daily Political
Associated Banc Corp Cuts Stake in AbbVie Inc. $ABBV - Stock Observer
The Smartest Growth Stocks to Invest $10,000 in As Investors Rotate Out of Tech
Final Trades: AbbVie, Millrose Properties, ADM, GE Vernova, Estee Lauder
Merck (MRK) and AbbVie (ABBV) Gain EU Panel Endorsements for New Treatments
AbbVie (ABBV) Receives Positive EMA Opinion for Maviret Approval
AbbVie Gets Positive Opinion From European Regulators on Hepatitis C Treatment | Morningstar
Rathbones Group PLC Lowers Position in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Bought by Axxcess Wealth Management LLC
Twenty-three abstracts will highlight the versatility and st
AbbVie Announces New Data at ASCO 2026 Demonstrating Breadth and Momentum Across its Next-Generation Oncology Pipeline
Allergan Aesthetics Receives Positive CHMP Opinion for Boey®
AbbVie (NYSE:ABBV) Trading 1.2% Higher - What's Next?
Genmab to Highlight Advances Across Its Oncology Portfolio at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) 2026 Congress | Morningstar
Hepatic Impairment Market Analysis Report 2026-2036 Featuring AbbVie, Astellas Pharma, Gilead Sciences, F. Hoffmann La Roche, and Takeda Pharmaceuticals
AbbVie Inc. (ABBV) Positioned for Long-Term Gains with IBD Pipeline Strength
AbbVie Inc. $ABBV Shares Acquired by Mach 1 Financial Group LLC - Stock Observer
AbbVie Inc. $ABBV Shares Acquired by ABN Amro Investment Solutions - Stock Observer
Assessing AbbVie (ABBV) Valuation After Recent Share Price Movement And Rich Earnings Multiple
Treat-to-target in Behçet syndrome
Hippocratic AI Expands Life Sciences Leadership Team as Pharma and Medtech Demand for Voice AI Agents Accelerates | Morningstar
Three Dividend-Paying Healthcare Giants: Pfizer (PFE), AbbVie (ABBV), and Medtronic (MDT) Compared for 2026
PNC Financial Services Group Inc. Sells 152,493 Shares of AbbVie Inc. $ABBV - Stock Observer
Cullen Frost Bankers Inc. Sells 16,653 Shares of AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Sold by Harvest Portfolios Group Inc.
Is AbbVie (ABBV) Now Attractive After Mixed Returns And Conflicting Valuation Signals?
Treatment strategies in giant cell arteritis and polymyalgia rheumatica: beyond glucocorticoids
Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?
AbbVie (NYSE:ABBV) Stock Price Up 2.1% - Time to Buy? - Stock Observer
BimzelxВ® Shows Superiority Over SkyriziВ® in Psoriatic Arthritis
AbbVie (ABBV) Price Target Lowered to $235 at Evercore ISI
Pharmaceutical Stocks To Follow Now - May 19th - Daily Political
ProShare Advisors LLC Sells 156,611 Shares of AbbVie Inc. $ABBV
2 Reasons to Like ABBV and 1 to Stay Skeptical
Csenge Advisory Group Purchases 12,983 Shares of AbbVie Inc. $ABBV
Gabelli Funds LLC Sells 19,750 Shares of AbbVie Inc. $ABBV
AMF Tjanstepension AB Lowers Stake in AbbVie Inc. $ABBV
Resona Asset Management Co. Ltd. Sells 24,330 Shares of AbbVie Inc. $ABBV - Stock Observer
Profund Advisors LLC Buys 7,561 Shares of AbbVie Inc. $ABBV - Daily Political
AbbVie Inc. $ABBV Shares Sold by Gabelli Funds LLC - Stock Observer
ProShare Advisors LLC Decreases Holdings in AbbVie Inc. $ABBV - Daily Political
Gambit Capital Management LLC Takes Position in AbbVie Inc. $ABBV - Daily Political
A multimodal biomarker strategy to enhance diagnostic precision in neurodegenerative parkinsonism
US pharma co denied patent on hepatitis C combo therapy
AbbVie loses patent plea for Hep C drug
AbbVie's trade secret suit against a Chinese rival gets green light
Mission Wealth Management LP Lowers Holdings in AbbVie Inc. $ABBV
60,762 Shares in AbbVie Inc. $ABBV Acquired by North Dakota State Investment Board - Stock Observer
AbbVie Inc. $ABBV Shares Purchased by RiverFront Investment Group LLC - Daily Political
Top Pharmaceutical Stocks To Keep An Eye On - May 17th - Stock Observer
Equities Research Analysts' Downgrades for May 17th (ABBV, ADTN, ALV, ANRO, ARTV, BETR, BIDU, BIOA, BL, BLNE) - Stock Observer
Dividend Stocks To Follow Now - May 16th - Daily Political
AbbVie Inc. $ABBV Shares Sold by WealthPlan Investment Management LLC
L & S Advisors Inc Has $8.01 Million Stake in AbbVie Inc. $ABBV
Millennium Capital Advisors LLC Makes New $2.71 Million Investment in AbbVie Inc. $ABBV - Zolmax
AbbVie Inc. $ABBV Shares Acquired by Cambridge Investment Research Advisors Inc.
Dividend Stocks To Follow Now - May 16th - Zolmax
Lawood & Co. Takes Position in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Sold by Thrivent Financial for Lutherans
AbbVie Inc. $ABBV Shares Acquired by Lockheed Martin Investment Management Co. - Stock Observer
Applied Finance Capital Management LLC Has $6.83 Million Stock Holdings in AbbVie Inc. $ABBV
Lawood & Co. Purchases Shares of 12,555 AbbVie Inc. $ABBV - Stock Observer
Commerzbank Aktiengesellschaft FI Sells 10,690 Shares of AbbVie Inc. $ABBV - Daily Political
Realty Income Has Raised Its Dividend 113 Consecutive Times. Here Is Why That Is Not Enough to Own It Right Now
AbbVie FY2027 EPS Forecast Boosted by Erste Group Bank
What AbbVie (ABBV)'s New IBD Data for SKYRIZI and RINVOQ Means For Shareholders - Simply Wall St News
AbbVie News
Markets.com Review 2026: Complete Account Opening Guide, Deposit, Withdrawal & Demo Test
S&P 500 Analysis: S&P 500 Trading Landscape Changes as Wall Street Reacts to Economic Data
Rivian Stock Price Prediction 2030: What South African Investors Need to Know about RIVN Stock?
AED/USD Exchange Rate Analysis: Why the AED is One of the Most Stable Currencies in Forex Right Now?
Top 10 best ETFs to invest in South Africa: Satrix 40 ETF, SYG500, STXDIV and more
Latest news
Show more
Gold Price Today, May 26: XAU/USD Holds Near $4,540 as Markets Weigh Fed Signals
Fed Leadership Change: Kevin Warsh Takes Over Federal Reserve at Critical Economic Moment
Gold Price Today, May 25: XAU/USD Opens Near $4,523 After Friday's Close at $4,509 on US-Iran Developments
Record-Breaking $500 Billion ETF Inflows in 2026: Historic Inflows Driven by US Stocks and EM Funds
Gold Price Today, May 22: XAU/USD Consolidates Near $4,520 Amid Fed Policy Uncertainty
